JP2023554317A5 - - Google Patents
Info
- Publication number
- JP2023554317A5 JP2023554317A5 JP2023535364A JP2023535364A JP2023554317A5 JP 2023554317 A5 JP2023554317 A5 JP 2023554317A5 JP 2023535364 A JP2023535364 A JP 2023535364A JP 2023535364 A JP2023535364 A JP 2023535364A JP 2023554317 A5 JP2023554317 A5 JP 2023554317A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- hydrogen
- independently
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124592P | 2020-12-11 | 2020-12-11 | |
| US63/124,592 | 2020-12-11 | ||
| PCT/US2021/062974 WO2022126000A1 (en) | 2020-12-11 | 2021-12-11 | Methods and compounds for modulating myotonic dystrophy 1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023554317A JP2023554317A (ja) | 2023-12-27 |
| JP2023554317A5 true JP2023554317A5 (https=) | 2024-12-19 |
Family
ID=81974018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535364A Pending JP2023554317A (ja) | 2020-12-11 | 2021-12-11 | 筋強直性ジストロフィー１を調節するための方法及び化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240166693A1 (https=) |
| EP (1) | EP4259133A4 (https=) |
| JP (1) | JP2023554317A (https=) |
| CN (1) | CN117279636A (https=) |
| AU (1) | AU2021396454A1 (https=) |
| CA (1) | CA3201756A1 (https=) |
| WO (1) | WO2022126000A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024502469A (ja) * | 2021-01-08 | 2024-01-19 | デザイン セラピューティクス，インク． | フリードライヒ運動失調症を治療するための方法及び化合物 |
| US20250120928A1 (en) * | 2021-07-14 | 2025-04-17 | University Of Maryland, Baltimore | Suberoylanilide hydroxamic acid (saha) drugs, conjugates, and nanoparticles, and methods of use thereof |
| KR20250016096A (ko) * | 2022-04-01 | 2025-02-03 | 디자인 테라퓨틱스, 인크. | 헌팅턴병을 조절하기 위한 방법 및 화합물 |
| US11976066B1 (en) | 2023-10-23 | 2024-05-07 | King Faisal University | Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents |
| GB202401731D0 (en) * | 2024-02-08 | 2024-03-27 | Univ Strathclyde | Polyamides |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1260006A (zh) * | 1996-02-26 | 2000-07-12 | 加利福尼亚州技术学院 | 双链dna和杂环低聚物之间复合物的形成 |
| US6506906B1 (en) * | 1996-02-26 | 2003-01-14 | California Institute Of Technology | Preparation and use of bifunctional molecules having DNA sequence binding specificity |
| US20060270727A1 (en) * | 2005-05-03 | 2006-11-30 | Christian Melander | Small molecule therapeutics and uses therefor |
| GB0722088D0 (en) * | 2007-11-09 | 2007-12-19 | Spirogen Ltd | Pyrrolobenzodiazepines |
| WO2010001933A1 (ja) * | 2008-07-01 | 2010-01-07 | 学校法人日本大学 | 標的遺伝子特異的ヒストン修飾制御剤 |
| US10517877B2 (en) * | 2016-03-30 | 2019-12-31 | Wisconsin Alumni Research Foundation | Compounds and methods for modulating frataxin expression |
| US20190343873A1 (en) * | 2018-05-14 | 2019-11-14 | Kyoto University | Sequence-selective gene expression regulators |
| EP4234549A1 (en) * | 2018-05-22 | 2023-08-30 | Design Therapeutics, Inc. | Methods and compounds for the treatment of genetic disease |
-
2021
- 2021-12-11 WO PCT/US2021/062974 patent/WO2022126000A1/en not_active Ceased
- 2021-12-11 EP EP21904532.5A patent/EP4259133A4/en active Pending
- 2021-12-11 AU AU2021396454A patent/AU2021396454A1/en active Pending
- 2021-12-11 CA CA3201756A patent/CA3201756A1/en active Pending
- 2021-12-11 JP JP2023535364A patent/JP2023554317A/ja active Pending
- 2021-12-11 US US18/256,864 patent/US20240166693A1/en active Pending
- 2021-12-11 CN CN202180093566.1A patent/CN117279636A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023554317A5 (https=) | ||
| JP2023516886A5 (https=) | ||
| JP2023011074A5 (https=) | ||
| ES2745504T3 (es) | Acidos nucleicos peptídicos gamma que contienen miniPEG preorganizados conformacionalmente | |
| WO2005070859A1 (ja) | フルオラス担体およびそれを用いたオリゴヌクレオチド誘導体の製造方法 | |
| JP2013505300A5 (https=) | ||
| JP2023513658A5 (https=) | ||
| JP2015521616A5 (https=) | ||
| JP2022533069A5 (https=) | ||
| JP2012515240A5 (https=) | ||
| JP2024502469A5 (https=) | ||
| JP2010520851A5 (https=) | ||
| JP2020514299A5 (https=) | ||
| JP2022501371A5 (https=) | ||
| AU2011315378A1 (en) | Peptides and uses | |
| Murr et al. | An octakis-intercalating molecule | |
| CN102653573B (zh) | 一种抗吸附、长循环脂质分子、其制备方法及其在医药和化妆品领域的应用 | |
| JP2024540097A5 (https=) | ||
| JP2008515782A5 (https=) | ||
| JP2011158341A (ja) | ペプチドのスクリーニング方法 | |
| JP2025512877A5 (https=) | ||
| JP5336189B2 (ja) | アミン結合基を有する架橋ポリマー類 | |
| JP4744054B2 (ja) | シラン化固体支持体上で核酸を合成および固定化するための方法 | |
| JP2020507346A5 (https=) | ||
| CA2155496A1 (en) | Nucleic acid-binding oligomers for therapy and diagnosis |